TRIPS Waiver 2.0 at the WTO: Proponents back at the table to push for therapeutics and diagnostics
Newsletter Edition #148 [The Curated Primer]
No matter the optics on the suggested success of the WTO’s 12th Ministerial Conference last month, the final outcome on the TRIPS Waiver discussions that resulted in a ministerial decision clarifying existing rules in the TRIPS Agreement, is mostly being seen as a blow to the goals of equitable access to medical products.
One activist described the M…
Keep reading with a 7-day free trial